Jason Raleigh Nunn Regulus Therapeutics Inc. (RGLS) insider trading activity

Jason Raleigh Nunn is of Regulus Therapeutics Inc.. Currently has a direct ownership of 62,500 shares of RGLS, which is worth approximately $489,375. The most recent transaction as insider was on Apr 30, 2025, when has been sold 62,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.5K

n/a 3M change

n/a 12M change

Total Value Held $489,375

Jason Raleigh Nunn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 30 2025	BUY Grant, award, or other acquisition	-	62,500 Added 50.0%	62,500 Common Stock

Also insider at

TRVN

TREVENA INC Healthcare

Director

ZBIO

Zenas BioPharma, Inc.

JRN